(Q38682497)

5 September 2017

1 reference

title

Advances in the assessment of disease activity in inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

5 September 2017

main subject

0 references

author name string

M Camilleri

series ordinal

1

1 reference

5 September 2017

M Proano

series ordinal

2

1 reference

5 September 2017

language of work or name

English

0 references

publication date

1 July 1989

1 reference

5 September 2017

1 reference

5 September 2017

volume

64

1 reference

5 September 2017

issue

7

1 reference

5 September 2017

page(s)

800-807

1 reference

Cortisone in ulcerative colitis; final report on a therapeutic trial.

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Assessment of drug therapy in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Short-term course and prognosis of Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

A simple index of Crohn's-disease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

An index of inflammatory activity in patients with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Development of a Crohn's index for survey research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

IOIBD report no 1: Observer variation in calculating indices of severity and activity in Crohn's disease. International Organisation for the Study of Inflammatory Bowel Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Erythrocytic sedimentation rate as a measure of clinical activity in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

C-reactive protein as a predictor of relapse in asymptomatic patients with Crohn's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Circulating human leucocyte elastase in patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Circulating immune complexes and disease activity in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Antibody-dependent cell-mediated cytotoxicity in serum samples from patients with ulcerative colitis. Relationship to disease activity and response to total colectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Neopterin as a new biochemical marker in the clinical assessment of ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

A simple index relating clinical activity in Crohn's disease with T cell activation: hematocrit, frequency of liquid stools and urinary neopterin as parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Faecal mucus degrading glycosidases in ulcerative colitis and Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Faecal sulphatase in health and in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Fecal alpha 1-antitrypsin clearance in patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Mucin secretion in inflammatory bowel disease: correlation with disease activity and dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Relationship between clinical and laboratory parameters and length of lesion in Crohn's disease of small bowel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Double-contrast radiography: colonic inflammatory disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

The small bowel enema made easy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Small bowel radiography: how, when, and why?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Perspective: the small bowel examination in the diagnosis of Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Extent of inflammatory lesions in ulcerative colitis assessed by radiology, colonoscopy, and endoscopic biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Symposium: Evaluation of the colonoscopic examination: results of three studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Assessment of disease activity in ulcerative colitis using indium-111-labelled leukocyte faecal excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Specificity of indium-111 granulocyte scanning and fecal excretion measurement in inflammatory bowel disease--an autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Value of indium-111 granulocyte scintigraphy in the assessment of Crohn's disease of the small intestine: prospective investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Fecal leukocytosis, indium-111-labelled autologous polymorphonuclear leukocyte abdominal scanning, and quantitative fecal indium-111 excretion in acute gastroenteritis and enteropathogen carriage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Assessment of inflammatory bowel disease activity by technetium 99m phagocyte scanning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

Crohn's disease of the small bowel examined by double contrast technique: A comparison with oral technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961753-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-6196(12)61753-4

1 reference

5 September 2017

1 reference